Low back and neck pain; 6 months after stem cell therapy by Dr Harry Adelson
Low back and neck pain; 6 months after stem cell therapy by Dr Harry Adelson http://www.docereclinics.com.
By: Harry Adelson, N.D.
See the original post:
Low back and neck pain; 6 months after stem cell therapy by Dr Harry Adelson - Video
Stem Cells and Multiple Sclerosis
Dr Colin Andrews speaks about the optimistic results of treating MS (multiple sclerosis) with stem cell therapy and the ethical limitations within Australia.
By: Norwood Day Surgery
Read the original:
Stem Cells and Multiple Sclerosis - Video
PUBLIC RELEASE DATE:
23-Apr-2014
Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair
Putnam Valley, NY. (Apr. 23, 2014) People who have had a stroke, often suffer motor deficits with little potential to restore neurological function. However, a study conducted in Taiwan, that will be published in a future issue of Cell Transplantation, but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen, has found that when one group of stroke victims had their own peripheral blood stem cells (PBSCs) injected directly into the brain and a similar group did not, those who received the PBSCs experienced some "improvement in stroke scales and functional outcome." Those in the PBSC-injected group also received injections of the growth factor granulocyte-colony stimulating factor (G-CSF), known to be potentially neuroprotective.
"In this phase 2 study, we provide the first evidence that intracerebral injection of autologous (self-donated) PBSCs can improve motor function in those who have suffered a stroke and have motor deficits as a result," said study corresponding Dr. Woei-Cheng Shyu of the Center for Neuropsychiatry, Graduate Institute of Immunology and Translational Medicine Research Center, China Medical University in Taiwan. "Our study demonstrated that this therapeutic strategy was feasible and safe in stroke patients who suffered a prior stroke, but within five years from the onset of symptoms."
According to the authors, there has been little advance made in restoring neurological function following ischemic stroke. However, since neuronal death is the primary mechanism that limits functional recovery, stem cell therapy is emerging as a potentially effective regenerative approach. Once more PBSCs are being increasingly used as a self-donated source for cell therapies for regenerating skeletal muscle, heart and neurons. The PBSCs may need to be "amplified" with G-CSF, speculated the researchers.
All of the patients in the trial had suffered a stroke in the past, as long as five years prior to this study. At the end of a 12 month follow-up, the group of 15 patients with neurological deficits who received injections of PBSCs experienced neurological and functional improvement based on a number of clinical outcomes measures. The control group of 15 patients with neurological deficits that did not receive the PBSC injections did not experience the same beneficial outcomes.
The researchers reported that nine of the 15 patients undergoing PBSC transplantation experienced "positive motor evoked potentials" (MEPs) after transcranial magnetic stimulation, but why MEPs appeared in some of the transplanted group, but not all, was unclear.
"Despite this success, it should be noted that this was a preliminary study and, due to the small number of patients, are tentative," concluded the researchers. "In the future we plan to conduct a multi-center, large-scale, double blind, placebo-controlled randomized studies to better evaluate the effect of PBSC implantation in patients suffering from the effects of past stroke."
"This phase II study offers pilot clinical evidence supporting the use of autologous stem cell-based treatment for stroke" said Dr. Cesar V. Borlongan, Prof. of Neurosurgery and Director of the Center of Excellence for Aging & Brain Repair at the University of South Florida. "Clarification of the impact of G-CSF on the cells and whether other factors are necessary to maximize the benefit of cell transplantation, as well as further studies with a larger number of patients are necessary to determine equivocal safety and efficacy of this treatment".
Read the original post:
Autologous stem cell therapy improves motor function in chronic stroke victims
Madison #39;s Before After Stem Cell Therapy
Had step cell therapy procedure on 4/14/14 and we were seeing noticeable results only 4 short days later.
By: Jaie Locke
Follow this link:
Madison's Before & After Stem Cell Therapy - Video
Tuesday, April 22 11:57:06
Orbsen Therapeutics, a spin-out from NUI Galway's Regenerative Medicine Institute (REMEDI), is to partner with the University of Birmingham in a E6 million EU FP7 funded MERLIN project to fight liver disease.
The EU FP7-funded project known by the acronym "MERLIN" (MEsynchymal stem cells to Reduce Liver INflammation) is led by Professor Phil Newsome, Clinical Director of the Birmingham University Stem Cell Centre. MERLIN will advance Orbsen's proprietary cell therapy to a Phase 2a clinical trial in patients with inflammatory liver disease. This MERLIN project will evaluate the Orbsen cell therapy in 4 different research laboratories across Europe and the project will culminate in a Phase 2a clinical trial of the therapy in the crippling inflammatory liver disease, Primary Sclerosing Cholangitis.
This is Orbsen's fourth success in attracting FP7 funding (the EU's Seventh Framework Programme for Research), making them one of Ireland's most successful private companies in this funding programme and now connects Orbsen to 23 global collaborators. Other successful cell therapy projects for Orbsen include PURSTEM (completed), REDDSTAR (ongoing) and DeCIDE (ongoing).
Orbsen Therapeutics Ltd. is a privately-held company founded in 2006 as a spin-out from Ireland's Regenerative Medicine Institute (REMEDI) in NUI Galway. As part of the PurStem EU FP7 program, Orbsen developed proprietary technologies that enable the prospective purification of highly defined and therapeutic (stromal) cells from several human tissues, including bone marrow, adipose tissue and umbilical cord.
Orbsen's CEO Brian Molloy said, "Orbsen has secured substantial amounts of research funding in the last 18 months which will further validate our product and bring us through to a "first in man" clinical trial in 2015/16. Our model has always focused on putting the 'science first' and we have successfully used that approach to develop a technology that could potentially position us and indeed Ireland at the leading edge of European Cell Therapy development."
Mr Molloy continued, "As a spin-out from the NUI Galway based REMEDI Institute we have focused the majority of our collaborations with an Irish research team. Our success in the MERLIN project now demonstrates that we are capable of playing a key role in collaborations led by researchers across Europe."
The total research budget for the MERLIN project is close to E6 Million of which E1 Million will go directly to Orbsen Therapeutics over the 4-year period of the project.
Continue reading here:
Irish cell therapy firm in E6m research
Ankle arthritis; 4 months after stem cell therapy by Dr Harry Adelson
Craig discusses his results from his stem cell therapy by Dr Harry Adelson for his arthritic ankle http://www.docereclinics.com.
By: Harry Adelson, N.D.
Originally posted here:
Ankle arthritis; 4 months after stem cell therapy by Dr Harry Adelson - Video
Othropedic Surgeon Dr. Propper Speaks about Stem Cell Therapy - PRP - BMAC
Orthopedic Surgeon Dr. Propper Speaks about the Difference of Stem Cell Injection Therapy PRP - BMAC.
By: Dennis Spoonhour, DC
More:
Othropedic Surgeon Dr. Propper Speaks about Stem Cell Therapy - PRP - BMAC - Video
Two Central Pennsylvania dogs are receiving a regenerative therapy for arthritis thats unprecedented for this area and less expensive than standard surgery. Stem Cell therapy is a way to repair damaged tissue and treat injury. When dealing with dogs, veterinarians say its the future of treatments and its becoming less costly.
Gunny is a 7-year-old German Shepard. He underwent the revolutionary stem cell therapy at the Palmyra Animal Clinic. Vets say the stem cell therapy is a way to combat Gunnys arthritis in his hips. Doctors collected fatty tissue from his shoulder, processed the stem cells in the lab and injected the cells back into his hips. This happens all in one day for around $1500. Prior to this, surgery could cost around $3,000.
Dr. Calvin Clements of the Palmyra Animal Clinic says, Injected in a damaged joint or ligament, these cells will take on that characteristic and differentiate into the cartilage or tissue were dealing with and help to regenerate it.
Dr. Clements says results are noticeable in about a month. On average, animals improve 85%.
For more information, contact the Palmyra Animal Clinic at 717-838-5451.
To learn more click here.
Link:
Stem Cell therapy on animals may be medicine of the future
Stem Cell Therapy for Chronic Pain
By: Latest Pain Relief Solutions
Visit link:
Stem Cell Therapy for Chronic Pain - Video
A doctor offering stem cell therapy may face charges for the death of a cancer patient who allegedly underwent treatment similar to that administered to former president and incumbent Pampanga Rep. Gloria Macapagal-Arroyo.
This was after it was found out that she is not a licensed doctor in the Philippines.
A report on GMA News TV's "News To Go" on Wednesday said a complaint has been filed against Dr. Antonia Carandang-Park at the National Bureau of Investigation (NBI) by Bernard Tan, who claims that his daughter, Kate, died after going through the said alternative treatment.Cancer patient Kate Tan received stem cell therapy from Dr. Antonia Carandang-Park, Gloria Arroyo's doctor.
Park owns the Tagaytay-based Green & Young Health and Wellness Center where Arroyoburdened by persistent trouble with her cervical spinesought treatment in 2012.
In an interview with GMA News, Tan said his daughter, who had Hodgkin's lymphoma (a type of cancer of the blood), was given "the same treatment that [Park] did with Gloria," which included "juicing diet, vegetable diet... acupuncture coffee enema, at 'yun na nga, stem cell."
Stem cell therapy introduces new adult stem cells into damaged tissue in order to treat disease or injury.
"Ang sabi niya, 'Give me three months, magaling na 'yan,'" Tan told GMA News. He added that his family was easily convinced to take their daughter to Park's wellness center because "Presidente na ng Pilipinas ang pumunta doon."
"Siguro naman na-scrutinize na nila 'yan, na-background check na nila 'yan," he said. "Kumbaga, 'yung credibility no'n, nag-build up na."
Kate was fed nothing but bananas and vegetable juices for three months, and had eight rounds of "embryonic" stem cell treatment, he said.
However, the 23-year-old lost even more weight, prompting the family to seek the assistance of a different doctor. Kate had eight rounds of 'embryonic' stem cell treatment, her father Bernard Tan said.Seven months later, in July 2013, Kate passed away.
View post:
Gloria Arroyos stem cell therapy doc blamed for cancer patient's death
New York, NY (PRWEB) April 09, 2014
The Stem Cell Institute, located in Panama City, Panama, will present an informational umbilical cord stem cell therapy seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm.
Speakers include:
Neil Riordan PhD Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury
Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.
Jorge Paz-Rodriguez MD Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus
Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.
Light snacks will be served afterwards. Our speakers and stem cell therapy patients will also be on hand to share their personal experiences and answer questions.
Admission is free but space in limited and registration is required. For venue information and to register and reserve your tickets today, please visit: http://www.eventbrite.com/e/stem-cell-institute-seminar-tickets-11115112601 or call Cindy Cunningham, Patient Events Coordinator, at 1 (800) 980-7836.
About Stem Cell Institute Panama
Desiccated L4/5 disc five months after stem cell therapy by Dr Harry Adelson
A decorated war hero, Chris, discusses the stem cell injection into his L4/5 disc by Dr Harry Adelson http://www.docereclinics.com.
By: Harry Adelson, N.D.
See the article here:
Desiccated L4/5 disc five months after stem cell therapy by Dr Harry Adelson - Video
New York, New York (PRWEB) April 03, 2014
Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat chronic foot pain.
Adler Footcare New York uses live birth stem cells to help treat patients with chronic foot problems such as: Plantar fasciitis, Osteoarthritis, Achilles tendonitis and torn soft tissue. The stem cell treatment is proving to be much more effective than traditional treatments like physical therapy or orthotic therapy.
Stem cells have the ability to replicate themselves or change into the cell type that is needed to repair damaged tissue. The therapy works by directly introducing live stem cells into the affected area causing pain. Its approved by the FDA and consistently reviewed by medical professionals to remove the potential of any communicable diseases.
Dr. Adler often travels to other states to share his knowledge with other doctors in his profession. His latest research on stem cell therapy has gained much interest among his peers in the medical industry.
When compared to traditional treatments, stem therapy is proving to be more successful and longer lasting, Dr. Adler said. We are seeing patients heal much quicker and return to their normal activities much sooner.
To learn more about stem cell replacement therapy or to schedule a consultation with a New York podiatrist at Adler Footcare, call (212) 704-4310 or visit http://www.mynycpodiatrist.com.
About Adler Footcare New York Dr. Jeffrey L. Adler, Medical/Surgical Director and owner of Adler Footcare New York has been practicing podiatric medicine since 1979 and has performed thousands of foot and ankle surgeries. Dr. Adler is board certified in Podiatric Surgery and Primary Podiatric Medicine by the American Board of Multiple Specialties in Podiatry. Dr. Adler is also a Professor of Minimally Invasive Foot Surgery for the Academy of Ambulatory Foot and Ankle Surgeons. As one of only several in the country who perform minimally invasive podiatric surgery, Dr. Adlers patients enjoy significantly reduced recovery times.
Follow this link:
New York Podiatrist Dr. Jeffrey Adler to Be Interviewed April 5 on NewsTalkRadio 77 WABC About the Use of Stem Cell ...
Diabetes Treatment at EmCell
At present, more than 200 million people around the world are affected with diabetes, and this number is growing year after year. Among various types of ther...
By: Stem Cell Therapy Center EMCELL
Grover before Stem Cell Therapy
This video is of Grover before his Stem Cell Therapy and after 12 sessions of Laser Therapy. Grover could not bear any weight on his leg prior to the Laser T...
By: Animal Haven Veterinary Center
Follow this link:
Grover before Stem Cell Therapy - Video
April 1, 2014
University of Nottingham
Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine.
Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products and treatments is how to mass-produce such a complex living material.
There are two distinct phases in the production of stem cell products; proliferation (making enough cells to form large tissue) and differentiation (turning the basic stem cells into functional cells). The material environment required for these two phases are different and up to now a single substance that does both jobs has not been available.
Now a multi-disciplinary team of researchers at Nottingham has created a new stem cell micro-environment which they have found has allowed both the self-renewal of cells and then their evolution into cardiomyocyte (heart) cells. The material is a hydrogel containing two polymers an alginate-rich environment which allows proliferation of cells with a simple chemical switch to render the environment collagen-rich when the cell population is large enough. This change triggers the next stage of cell growth when cells develop a specific purpose.
Major priority
Professor of Advanced Drug Delivery and Tissue Engineering, Kevin Shakesheff, said:
Our new combination of hydrogels is a first. It allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before. The discovery has important implications for the future of manufacturing in regenerative medicine. This field of healthcare is a major priority for the UK and we are seeing increasing investment in future manufacturing processes to ensure we are ready to deliver real treatments to patients when HPSC products and treatments go to trial and become standard.
The research, Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation, is published in the Proceedings of the National Academy of Sciences (PNAS).
Read the original here:
Big Breakthrough In Stem Cell Manufacturing Technology
Dr Antonia Park, according to the Professional Regulatory Commission, is not authorized to practice medicine in the Philippines. She faces charges of estafa and reckless imprudence resulting in homicide.
MANILA, Philippines The alternative medicine doctor who took in former president Gloria Macapagal-Arroyo in 2012 for possible stem cell therapy is not licensed to practice in the Philippines.
On Tuesday, April 1, Antonia Park of the Green & Young Health & Wellness Center admitted to Rappler in a phone interview she is not a registered physician in the Philippines because "I'm not from here." She is instead a registered medical practitioner in London and Korea.
"Thats why its a wellness center. If dito ako [registered], maglalagay na lang ako ng medical center," she said, referring to her center located in Tagaytay City. (That's why it's a wellness center. If I am registered here, I might as well put up a medical center.)
A document from the Professional Regulatory Commission (PRC) dated Aug 12, 2013 showed Park is not in the database of physicians which contains the names of those duly authorized to practice medicine in the Philippines.
Certification Antonia Carandang Park
Park and some of her clinic staff are facing charges of estafa and reckless imprudence resulting in homicide. The charges were filed last year by businessman Bernard Tan with the National Bureau of Investigation (NBI) after his 23-year-old daughter Kate died.
Kate, an Ateneo student who graduated with honors in March 2013, died 4 months later on July 4, due to a tumor that blocked the entry of blood to her heart, secondary to Hodgkin's Lymphoma. The disease is an uncommon but curable cancer of the lymphatic system.
High-profile patient
Read this article:
Arroyo's alternative medicine doctor unlicensed
Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine.
Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products and treatments is how to mass-produce such a complex living material.
There are two distinct phases in the production of stem cell products; proliferation (making enough cells to form large tissue) and differentiation (turning the basic stem cells into functional cells). The material environment required for these two phases are different and up to now a single substance that does both jobs has not been available.
Now a multi-disciplinary team of researchers at Nottingham has created a new stem cell micro-environment which they have found has allowed both the self-renewal of cells and then their evolution into cardiomyocyte (heart) cells. The material is a hydrogel containing two polymers -- an alginate-rich environment which allows proliferation of cells with a simple chemical switch to render the environment collagen-rich when the cell population is large enough. This change triggers the next stage of cell growth when cells develop a specific purpose.
Professor of Advanced Drug Delivery and Tissue Engineering, Kevin Shakesheff, said:
"Our new combination of hydrogels is a first. It allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before. The discovery has important implications for the future of manufacturing in regenerative medicine. This field of healthcare is a major priority for the UK and we are seeing increasing investment in future manufacturing processes to ensure we are ready to deliver real treatments to patients when HPSC products and treatments go to trial and become standard."
The research, "Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation" is published in the Proceedings of the National Academy of Sciences (PNAS).
Story Source:
The above story is based on materials provided by University of Nottingham. Note: Materials may be edited for content and length.
Read more:
Major breakthrough in stem cell manufacturing technology
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements
Jamie Richie discussed her treatments and improvements while undergoing her third round of stem cell therapy at the Stem Cell Institute in Panama City, Panam...
By: http://www.cellmedicine.com
Originally posted here:
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements - Video